With few exceptions, the most commonly recommended triple Helicobacter pylori regimen
(proton pump inhibitor (PPI), amoxicillin and clarithromycin) now provides unacceptably low …

Background: Guidelines on the management of Helicobacter pylori, which cover indications
for management and treatment strategies, were produced in 2000. Aims: To update the …

Background & Aims A number of double, triple, and quadruple therapies have been
proposed as first-line empiric treatments for Helicobacter pylori infection. However …

Objective To do a systematic review and meta-analysis of studies comparing sequential
therapy for eradication of Helicobacter pylori with pre-existing and new therapies, thus …

Background Whether sequential treatment can replace triple therapy as the standard
treatment for Helicobacter pylori infection is unknown. We compared the efficacy of …

Helicobacter pylori (H. pylori) is an important major cause of peptic ulcer disease and gastric
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …

Active smokers and those exposed to secondhand smoke are at increased risk of bacterial
infection. Tobacco smoke exposure increases susceptibility to respiratory tract infections …

Background: Antimicrobial resistance has decreased eradication rates for Helicobacter
pylori infection worldwide. Objective: To determine whether sequential treatment eradicates …

OBJECTIVES: Eradication rates with triple therapy (TT) forHelicobacter pyloriinfection have
declined to unacceptable levels. Sequential therapy (ST) is a novel treatment that has …

Background: Standard proton-pump inhibitor–based therapy for Helicobacter pylori infection
fails in up to one quarter of patients. Sequential therapy may be more efficacious. Purpose …